期刊文献+

非酒精性脂肪性肝病与糖尿病 被引量:8

Non-alcoholic fatty liver disease and diabetes mellitus
下载PDF
导出
摘要 非酒精性脂肪性肝病(NAFLD)是从简单的脂肪变性(又名非酒精性脂肪肝)发展到非酒精性脂肪性肝炎(NASH)以及肝硬化、肝癌的一系列疾病谱。NAFLD反映了疾病严重程度的频谱性改变,它并非单一的代谢紊乱。本文从NAFLD的定义着手,讲述了肝脂肪变性的评估和量化,NAFLD的流行病学和发病机制,以及与NAFLD相关的内分泌代谢紊乱。饮食和肠道菌群可促进NAFLD的发生和发展。基于流行病学、饮食习惯和肥胖等相关因素,糖尿病与NAFLD之间关系密切,二者形成了恶性循环。饮食及药物干预可在一定程度上缓解NAFLD与糖尿病的发生及发展。 Non-alcoholic fatty liver disease(NAFLD)is a spectrum of disorders ranging from simple steatosis(non-alcoholic fatty liver,NAFL)to non-alcoholic steatohepatitis(NASH),cirrhosis and cancer.As a spectrum of severity,NAFLD is not a single metabolic disorder.This article begins with the definition of NAFLD,describes the assessment and quantification of hepatic steatosis,the epidemiology and pathogenesis of NAFLD,and the endocrine and metabolic disorders associated with NAFLD.Diet and intestinal flora can promote the occurrence and development of NAFLD.Based on epidemiology,dietary habits and obesity and other related factors,diabetes and NAFLD are closely related.Furthermore,the two have formed a vicious circle.To some extent,diet and drug intervention can alleviate the incidence and development of NAFLD and diabetes mellitus.
出处 《临床荟萃》 CAS 2017年第8期649-653,共5页 Clinical Focus
关键词 脂肪肝 非酒精性 肝炎 非酒精性 糖尿病 饮食 肠道菌群 fatty liver non-alcoholic hepatitis non-alcoholic steatohepatitis diabetes mellitus diet intestinal flora
  • 相关文献

参考文献1

二级参考文献20

  • 1Sanyal Arun J,Chalasani Naga,Kowdley Kris V,McCullough Arthur,Diehl Anna Mae,Bass Nathan M,Neuschwander-Tetri Brent A,Lavine Joel E,Tonascia James,Unalp Aynur,Van Natta Mark,Clark Jeanne,Brunt Elizabeth M,Kleiner David E,Hoofnagle Jay H,Rob.Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. The New England Quarterly . 2010
  • 2Yoneda Masato,Fujita Koji,Nozaki Yuichi,Endo Hiroki,Takahashi Hirokazu,Hosono Kunihiro,Suzuki Kaori,Mawatari Hironori,Kirikoshi Hiroyuki,Inamori Masahiko,Saito Satoru,Iwasaki Tomoyuki,Terauchi Yasuo,Kubota Kensuke,Maeyama Shiro,Nakajima Ats.Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: An open-label, pilot study. Hepatology research : the official journal of the Japan Society of Hepatology . 2010
  • 3Lisa B. VanWagner,Hongyan Ning,Cora E. Lewis,Christina M. Shay,John Wilkins,J. Jeffrey Carr,James G. Terry,Donald M. Lloyd-Jones,David R. Jacobs,Mercedes R. Carnethon.Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: The Coronary Artery Risk Development in Young Adults Study[J]. Atherosclerosis . 2014 (2)
  • 4Rasha AlShaalan,Murad Aljiffry,Said Al-Busafi,Peter Metrakos,Mazen Hassanain.Nonalcoholic fatty liver disease: Noninvasive methods of diagnosing hepatic steatosis[J]. Saudi Journal of Gastroenterology . 2015 (2)
  • 5Lynnda J. N. Tienhoven‐Wind,Robin P. F. Dullaart.Low–normal thyroid function and the pathogenesis of common cardio‐metabolic disorders[J]. Eur J Clin Invest . 2015 (5)
  • 6Jia Liu,Yuan Xu,Yanjin Hu,Guang Wang.The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy[J]. Metabolism . 2014
  • 7H. Perazzo,M. Munteanu,Y. Ngo,P. Lebray,N. Seurat,F. Rutka,M. Couteau,S. Jacqueminet,P. Giral,D. Monneret,F. Imbert‐Bismut,V. Ratziu,A. Hartemann‐Huertier,C. Housset,T. Poynard.Prognostic value of liver fibrosis and steatosis biomarkers in type‐2 diabetes and dyslipidaemia[J]. Aliment Pharmacol Ther . 2014 (9)
  • 8L. Fedchuk,F. Nascimbeni,R. Pais,F. Charlotte,C. Housset,V. Ratziu.Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease[J]. Aliment Pharmacol Ther . 2014 (10)
  • 9S. Savastano,C. Di Somma,A. Colao,L. Barrea,F. Orio,C. Finelli,F. Pasanisi,F. Contaldo,G. Tarantino.Preliminary data on the relationship between circulating levels of sirtuin 4, anthropometric and metabolic parameters in obese subjects according to growth hormone/insulin-like growth factor-1 status[J]. Growth Hormone & IGF Research . 2014
  • 10Simone Moreira de Macêdo,Talita Antunes,John David Feltenberger,Sérgio Henrique Sousa Santos.The role of renin-angiotensin system modulation on treatment and prevention of liver diseases[J]. Peptides . 2014

共引文献12

同被引文献105

引证文献8

二级引证文献109

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部